
News from 2000 AD
Top 2000 AD News

Artificial IntelligenceOral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option...See the Story
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
67% Right coverage: 3 sources
